Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples